
    
      The primary objective of this study will be to determine the potential of Diltiazem
      Hydrochloride 2% Cream and its vehicle to induce sensitization by repeated topical
      application to the skin of healthy subjects under controlled conditions. In addition, the
      irritation potential of the investigational products will be assessed during the Induction
      Phase and safety will be assessed by evaluation of any adverse events (AEs) reported during
      the study.
    
  